Enterprise Imaging 2030 and beyond —Elevating Care, Powering the Intelligent Future- Sponsored by AGFA HealthCare
Dr. Linda Chu sits down with Dr. Anjum Ahmed, Chief Medical Officer at AGFA HealthCare, to explore how enterprise imaging is shaping the future of radiology through AI-driven workflows, human-centered design, and personalized patient care. Together, they discuss what "Imaging the Individual" means for radiologists today and what radiology might look like in 2030 and beyond. Sponsored by AGFA HealthCare.
--------
32:59
--------
32:59
Leadership and Legacy with Dr. Jeffrey Klein
Dr. Jeffrey Klein joins host Dr. Refky Nicola to reflect on his journey from aspiring internist to thoracic radiologist and longtime RSNA leader. He shares lessons from his tenure as Radiographics editor, insights on fostering community at the RSNA annual meeting, and timeless advice for the next generation of radiologists.
--------
15:19
--------
15:19
Rethinking Risk in Nasopharyngeal Carcinoma
Our host, Dr. Celina Nahyun Jo, explores how identifying middle neck lymph node involvement can reshape clinical decision-making for nasopharyngeal carcinoma. Joined by Dr. Heejun Kang, they break down how this imaging finding could refine risk groups and potentially shift treatment intensity for certain patients. MRI-based Middle Neck Involvement in Stage N1–N2 Nasopharyngeal Carcinoma: A Marker for Risk Stratification. Qin and Jiang et al. Radiology 2025; 316(2):e243399. Middle Neck Involvement: New Layer of Risk Stratification in Nasopharyngeal Carcinoma. Jabehdar Maralani and Kang. Radiology 2025; 316(2):e252512.
--------
16:34
--------
16:34
Imaging the Future: A Conversation with Dr. Moy
Host Dr. Reni Butler sits down with outgoing Radiology Editor-in-Chief Dr. Linda Moy for an inspiring conversation about leadership, innovation, and the future of medical imaging. Dr. Moy reflects on her tenure at the journal, the impact of AI on radiology, and her vision for the next era of patient-centered care.
--------
16:35
--------
16:35
Detecting Oligometastatic Breast Cancer with FDG PET-CT
*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "e42a2a6c-9e77-4666-b10e-7691827934f9" data-testid= "conversation-turn-2" data-scroll-anchor="false" data-turn= "assistant"> Dr. Ashwin Singh Parihar speaks with Dr. Gary Ulaner about new research comparing FDG PET-CT and conventional imaging for detecting oligometastatic breast cancer. They explore how advanced imaging can improve staging accuracy, the challenges of detecting lobular cancer, and the evolving role of targeted therapies in this emerging field. 18F-FDG PET/CT of Oligometastatic Disease in LocallyAdvanced Breast Cancer: PETABC Trial Post Hoc Analysis. Metser et al. adiology 2025; 316(2):e243788. Detection of Oligometastatic Disease in Breast Cancer:It's the Little Things That Count. Ulaner. Radiology 2025; 316(2):e251797. *]:pointer-events-auto scroll-mt-(--header-height)" dir="auto" tabindex="-1" data-turn-id= "9d3f7fd2-373c-4ad3-b3a6-9ecb2673123d" data-testid= "conversation-turn-3" data-scroll-anchor="false" data-turn="user">
Radiology Podcast Editor Linda Chu, MD and guests discuss recently published research in Radiology. Subscribe today on Apple Podcasts, Google Play, Spotify, or ask Alexa to "play Radiology podcasts on TuneIn".
México